New research supports early evaluation and prevention of advanced liver damage among at-risk patients
Atlantic Gastroenterology underscores the importance of early screening to our patients in Brooklyn, greater New York City, and the Tri-State Area. Furthermore, our team, led by board-certified gastroenterologist Dr. Alexander Shapsis, stays on the leading edge of research that supports proactive diagnoses, risk reduction and prevention, and early treatment of nonalcoholic fatty liver disease (NAFLD) and other conditions. Notably, a study published in the November 1, 2022, issue of The Journal of Clinical Investigation demonstrates great promise for our ability to identify and prevent advanced fibrosis among first-degree relatives of those individuals with this form of liver damage. Fibrosis arises … Continue reading
